IL1B and chronic obstructive pulmonary disease: In conjunction with this, known inflammasome inhibitors were able to resolve the release of IL-1β from CepEV-stimulated macrophages, highlighting the inflammasome as a key feature of the epithelial-macrophage inflammatory cross-talk in COPD.